SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharmaceuticals informs about disclosure

10 Mar 2026 Evaluate
Kwality Pharmaceuticals has informed that it enclosed Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Updation on Bioequivalence (BE) Program- Successful Completion of Phase 1 by Kwality Pharmaceuticals. 

The above information is a part of company’s filings submitted to BSE.

Kwality Pharma Share Price

1648.80 -15.50 (-0.93%)
21-Apr-2026 10:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.50
Dr. Reddys Lab 1223.85
Cipla 1231.90
Zydus Lifesciences 932.25
Lupin 2327.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×